vs
费森尤斯医疗（FMS）与Genuine Parts Company（GPC）财务数据对比。点击上方公司名可切换其他公司
Genuine Parts Company的季度营收约是费森尤斯医疗的1.1倍（$6.3B vs $5.5B），费森尤斯医疗净利率更高（7.9% vs 3.0%，领先4.9%），Genuine Parts Company同比增速更快（6.8% vs -0.3%）
费森尤斯医疗是德国知名医疗保健企业，核心业务为肾脏透析服务，在全球运营4171家门诊透析中心，服务约34.54万名患者。公司主要为终末期肾病患者提供治疗服务，该类患者需终身每周接受3次透析治疗以维持生命。
Genuine Parts Company（简称GPC）是总部位于美国佐治亚州亚特兰大的汽车及工业零部件分销商，1928年由卡莱尔与马尔科姆·弗雷泽兄弟创立，现有约6万名员工，业务覆盖美国、澳大拉西亚、欧洲、墨西哥等十余个国家和地区。
FMS vs GPC — 直观对比
营收规模更大
GPC
是对方的1.1倍
$5.5B
营收增速更快
GPC
高出7.1%
-0.3%
净利率更高
FMS
高出4.9%
3.0%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $5.5B | $6.3B |
| 净利润 | $434.2M | $188.5M |
| 毛利率 | 27.4% | 37.3% |
| 营业利润率 | 11.7% | 67.2% |
| 净利率 | 7.9% | 3.0% |
| 营收同比 | -0.3% | 6.8% |
| 净利润同比 | 240.4% | -3.0% |
| 每股收益（稀释后） | — | $1.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FMSGPC
| Q1 26 | — | $6.3B | ||
| Q4 25 | $5.5B | $6.0B | ||
| Q3 25 | — | $6.3B | ||
| Q2 25 | — | $6.2B | ||
| Q1 25 | — | $5.9B | ||
| Q4 24 | $5.5B | $5.8B | ||
| Q3 24 | — | $6.0B | ||
| Q2 24 | — | $6.0B |
净利润FMSGPC
| Q1 26 | — | $188.5M | ||
| Q4 25 | $434.2M | $-609.5M | ||
| Q3 25 | — | $226.2M | ||
| Q2 25 | — | $254.9M | ||
| Q1 25 | — | $194.4M | ||
| Q4 24 | $127.6M | $133.1M | ||
| Q3 24 | — | $226.6M | ||
| Q2 24 | — | $295.5M |
毛利率FMSGPC
| Q1 26 | — | 37.3% | ||
| Q4 25 | 27.4% | 35.0% | ||
| Q3 25 | — | 37.4% | ||
| Q2 25 | — | 37.7% | ||
| Q1 25 | — | 37.1% | ||
| Q4 24 | 25.0% | 35.9% | ||
| Q3 24 | — | 36.8% | ||
| Q2 24 | — | 36.6% |
营业利润率FMSGPC
| Q1 26 | — | 67.2% | ||
| Q4 25 | 11.7% | -13.8% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 5.5% | ||
| Q1 25 | — | 4.3% | ||
| Q4 24 | 5.1% | 2.9% | ||
| Q3 24 | — | 5.0% | ||
| Q2 24 | — | 6.5% |
净利率FMSGPC
| Q1 26 | — | 3.0% | ||
| Q4 25 | 7.9% | -10.1% | ||
| Q3 25 | — | 3.6% | ||
| Q2 25 | — | 4.1% | ||
| Q1 25 | — | 3.3% | ||
| Q4 24 | 2.3% | 2.3% | ||
| Q3 24 | — | 3.8% | ||
| Q2 24 | — | 5.0% |
每股收益（稀释后）FMSGPC
| Q1 26 | — | $1.37 | ||
| Q4 25 | — | $-4.38 | ||
| Q3 25 | — | $1.62 | ||
| Q2 25 | — | $1.83 | ||
| Q1 25 | — | $1.40 | ||
| Q4 24 | — | $0.96 | ||
| Q3 24 | — | $1.62 | ||
| Q2 24 | — | $2.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.7B | $500.0M |
| 总债务越低越好 | — | $4.6B |
| 股东权益账面价值 | $15.4B | $4.5B |
| 总资产 | $33.5B | $21.0B |
| 负债/权益比越低杠杆越低 | — | 1.03× |
8季度趋势，按日历期对齐
现金及短期投资FMSGPC
| Q1 26 | — | $500.0M | ||
| Q4 25 | $1.7B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
总债务FMSGPC
| Q1 26 | — | $4.6B | ||
| Q4 25 | — | $4.8B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $4.3B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益FMSGPC
| Q1 26 | — | $4.5B | ||
| Q4 25 | $15.4B | $4.4B | ||
| Q3 25 | — | $4.8B | ||
| Q2 25 | — | $4.7B | ||
| Q1 25 | — | $4.4B | ||
| Q4 24 | $17.0B | $4.3B | ||
| Q3 24 | — | $4.7B | ||
| Q2 24 | — | $4.5B |
总资产FMSGPC
| Q1 26 | — | $21.0B | ||
| Q4 25 | $33.5B | $20.8B | ||
| Q3 25 | — | $20.7B | ||
| Q2 25 | — | $20.4B | ||
| Q1 25 | — | $19.8B | ||
| Q4 24 | $36.3B | $19.3B | ||
| Q3 24 | — | $20.3B | ||
| Q2 24 | — | $18.9B |
负债/权益比FMSGPC
| Q1 26 | — | 1.03× | ||
| Q4 25 | — | 1.08× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.99× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.9B | — |
| 自由现金流经营现金流 - 资本支出 | — | $-33.6M |
| 自由现金流率自由现金流/营收 | — | -0.5% |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 6.67× | — |
| 过去12个月自由现金流最近4个季度 | — | $548.0M |
8季度趋势，按日历期对齐
经营现金流FMSGPC
| Q1 26 | — | — | ||
| Q4 25 | $2.9B | $380.1M | ||
| Q3 25 | — | $341.6M | ||
| Q2 25 | — | $209.9M | ||
| Q1 25 | — | $-40.8M | ||
| Q4 24 | $2.6B | $155.0M | ||
| Q3 24 | — | $484.3M | ||
| Q2 24 | — | $293.6M |
自由现金流FMSGPC
| Q1 26 | — | $-33.6M | ||
| Q4 25 | — | $260.7M | ||
| Q3 25 | — | $240.0M | ||
| Q2 25 | — | $81.0M | ||
| Q1 25 | — | $-160.7M | ||
| Q4 24 | — | $-26.7M | ||
| Q3 24 | — | $358.0M | ||
| Q2 24 | — | $150.1M |
自由现金流率FMSGPC
| Q1 26 | — | -0.5% | ||
| Q4 25 | — | 4.3% | ||
| Q3 25 | — | 3.8% | ||
| Q2 25 | — | 1.3% | ||
| Q1 25 | — | -2.7% | ||
| Q4 24 | — | -0.5% | ||
| Q3 24 | — | 6.0% | ||
| Q2 24 | — | 2.5% |
资本支出强度FMSGPC
| Q1 26 | — | — | ||
| Q4 25 | — | 2.0% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 2.0% | ||
| Q4 24 | — | 3.1% | ||
| Q3 24 | — | 2.1% | ||
| Q2 24 | — | 2.4% |
现金转化率FMSGPC
| Q1 26 | — | — | ||
| Q4 25 | 6.67× | — | ||
| Q3 25 | — | 1.51× | ||
| Q2 25 | — | 0.82× | ||
| Q1 25 | — | -0.21× | ||
| Q4 24 | 20.20× | 1.17× | ||
| Q3 24 | — | 2.14× | ||
| Q2 24 | — | 0.99× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
